| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 59.628 | 100.169 | 184.886 | 255.051 |
| Total Income - EUR | - | - | - | - | - | - | 59.628 | 100.171 | 184.891 | 259.161 |
| Total Expenses - EUR | - | - | - | - | - | - | 24.608 | 81.257 | 148.983 | 169.638 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 35.021 | 18.915 | 35.908 | 89.523 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 34.436 | 18.033 | 34.151 | 81.871 |
| Employees | - | - | - | - | - | - | 2 | 4 | 10 | 8 |
Check the financial reports for the company - Onys Terapia S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 2.434 | 13.976 |
| Current Assets | - | - | - | - | - | - | 44.268 | 33.828 | 46.086 | 82.296 |
| Inventories | - | - | - | - | - | - | 6.776 | 30.924 | 33.262 | 38.164 |
| Receivables | - | - | - | - | - | - | 27.481 | 1.965 | 7.453 | 43.555 |
| Cash | - | - | - | - | - | - | 10.011 | 939 | 5.371 | 577 |
| Shareholders Funds | - | - | - | - | - | - | 34.477 | 18.165 | 34.268 | 81.973 |
| Social Capital | - | - | - | - | - | - | 40 | 61 | 61 | 60 |
| Debts | - | - | - | - | - | - | 9.791 | 15.663 | 14.251 | 14.299 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4727 - 4727" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Onys Terapia S.r.l.